Report Detail
Global OTC Anti-Infective Products Market Growth 2019-2024
- RnM3128231 |
- 14 March, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
According to this study, over the next five years the OTC Anti-Infective Products market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in OTC Anti-Infective Products business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Anti-Infective Products market by product type, application, key manufacturers and key regions and countries.
This study considers the OTC Anti-Infective Products value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Antifungals
Antiseptic
Antiparasitics
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global OTC Anti-Infective Products consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of OTC Anti-Infective Products market by identifying its various subsegments.
Focuses on the key global OTC Anti-Infective Products manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the OTC Anti-Infective Products with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of OTC Anti-Infective Products submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global OTC Anti-Infective Products Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global OTC Anti-Infective Products Consumption 2014-2024
- 2.1.2 OTC Anti-Infective Products Consumption CAGR by Region
- 2.2 OTC Anti-Infective Products Segment by Type
- 2.2.1 Antifungals
- 2.2.2 Antiseptic
- 2.2.3 Antiparasitics
- 2.3 OTC Anti-Infective Products Consumption by Type
- 2.3.1 Global OTC Anti-Infective Products Consumption Market Share by Type (2014-2019)
- 2.3.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global OTC Anti-Infective Products Sale Price by Type (2014-2019)
- 2.4 OTC Anti-Infective Products Segment by Application
- 2.4.1 Hospital Pharmacies
- 2.4.2 Drug Stores
- 2.4.3 Retail Stores
- 2.4.4 E-Commerce
- 2.5 OTC Anti-Infective Products Consumption by Application
- 2.5.1 Global OTC Anti-Infective Products Consumption Market Share by Application (2014-2019)
- 2.5.2 Global OTC Anti-Infective Products Value and Market Share by Application (2014-2019)
- 2.5.3 Global OTC Anti-Infective Products Sale Price by Application (2014-2019)
3 Global OTC Anti-Infective Products by Players
- 3.1 Global OTC Anti-Infective Products Sales Market Share by Players
- 3.1.1 Global OTC Anti-Infective Products Sales by Players (2017-2019)
- 3.1.2 Global OTC Anti-Infective Products Sales Market Share by Players (2017-2019)
- 3.2 Global OTC Anti-Infective Products Revenue Market Share by Players
- 3.2.1 Global OTC Anti-Infective Products Revenue by Players (2017-2019)
- 3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Players (2017-2019)
- 3.3 Global OTC Anti-Infective Products Sale Price by Players
- 3.4 Global OTC Anti-Infective Products Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global OTC Anti-Infective Products Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players OTC Anti-Infective Products Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 OTC Anti-Infective Products by Regions
- 4.1 OTC Anti-Infective Products by Regions
- 4.1.1 Global OTC Anti-Infective Products Consumption by Regions
- 4.1.2 Global OTC Anti-Infective Products Value by Regions
- 4.2 Americas OTC Anti-Infective Products Consumption Growth
- 4.3 APAC OTC Anti-Infective Products Consumption Growth
- 4.4 Europe OTC Anti-Infective Products Consumption Growth
- 4.5 Middle East & Africa OTC Anti-Infective Products Consumption Growth
5 Americas
- 5.1 Americas OTC Anti-Infective Products Consumption by Countries
- 5.1.1 Americas OTC Anti-Infective Products Consumption by Countries (2014-2019)
- 5.1.2 Americas OTC Anti-Infective Products Value by Countries (2014-2019)
- 5.2 Americas OTC Anti-Infective Products Consumption by Type
- 5.3 Americas OTC Anti-Infective Products Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC OTC Anti-Infective Products Consumption by Countries
- 6.1.1 APAC OTC Anti-Infective Products Consumption by Countries (2014-2019)
- 6.1.2 APAC OTC Anti-Infective Products Value by Countries (2014-2019)
- 6.2 APAC OTC Anti-Infective Products Consumption by Type
- 6.3 APAC OTC Anti-Infective Products Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe OTC Anti-Infective Products by Countries
- 7.1.1 Europe OTC Anti-Infective Products Consumption by Countries (2014-2019)
- 7.1.2 Europe OTC Anti-Infective Products Value by Countries (2014-2019)
- 7.2 Europe OTC Anti-Infective Products Consumption by Type
- 7.3 Europe OTC Anti-Infective Products Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa OTC Anti-Infective Products by Countries
- 8.1.1 Middle East & Africa OTC Anti-Infective Products Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa OTC Anti-Infective Products Value by Countries (2014-2019)
- 8.2 Middle East & Africa OTC Anti-Infective Products Consumption by Type
- 8.3 Middle East & Africa OTC Anti-Infective Products Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 OTC Anti-Infective Products Distributors
- 10.3 OTC Anti-Infective Products Customer
11 Global OTC Anti-Infective Products Market Forecast
- 11.1 Global OTC Anti-Infective Products Consumption Forecast (2019-2024)
- 11.2 Global OTC Anti-Infective Products Forecast by Regions
- 11.2.1 Global OTC Anti-Infective Products Forecast by Regions (2019-2024)
- 11.2.2 Global OTC Anti-Infective Products Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global OTC Anti-Infective Products Forecast by Type
- 11.8 Global OTC Anti-Infective Products Forecast by Application
12 Key Players Analysis
- 12.1 GlaxoSmithKline
- 12.1.1 Company Details
- 12.1.2 OTC Anti-Infective Products Product Offered
- 12.1.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 GlaxoSmithKline News
- 12.2 Merck
- 12.2.1 Company Details
- 12.2.2 OTC Anti-Infective Products Product Offered
- 12.2.3 Merck OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merck News
- 12.3 Pfizer
- 12.3.1 Company Details
- 12.3.2 OTC Anti-Infective Products Product Offered
- 12.3.3 Pfizer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Pfizer News
- 12.4 Novartis
- 12.4.1 Company Details
- 12.4.2 OTC Anti-Infective Products Product Offered
- 12.4.3 Novartis OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Novartis News
- 12.5 Abbott
- 12.5.1 Company Details
- 12.5.2 OTC Anti-Infective Products Product Offered
- 12.5.3 Abbott OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Abbott News
- 12.6 Sanofi
- 12.6.1 Company Details
- 12.6.2 OTC Anti-Infective Products Product Offered
- 12.6.3 Sanofi OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Sanofi News
- 12.7 Bristol-Myers Squibb
- 12.7.1 Company Details
- 12.7.2 OTC Anti-Infective Products Product Offered
- 12.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Bristol-Myers Squibb News
- 12.8 Roche
- 12.8.1 Company Details
- 12.8.2 OTC Anti-Infective Products Product Offered
- 12.8.3 Roche OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Roche News
- 12.9 NanoViricides
- 12.9.1 Company Details
- 12.9.2 OTC Anti-Infective Products Product Offered
- 12.9.3 NanoViricides OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 NanoViricides News
- 12.10 Novabay Pharmaceuticals
- 12.10.1 Company Details
- 12.10.2 OTC Anti-Infective Products Product Offered
- 12.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Novabay Pharmaceuticals News
- 12.11 Optimer Pharmaceuticals
- 12.12 Basilea Pharmaceutica
- 12.13 MerLion Pharma
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on OTC Anti-Infective Products . Industry analysis & Market Report on OTC Anti-Infective Products is a syndicated market report, published as Global OTC Anti-Infective Products Market Growth 2019-2024. It is complete Research Study and Industry Analysis of OTC Anti-Infective Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
